TerminatedPhase 2NCT03866200
Resveratrol Trial for Relief of Pain in Pseudoachondroplasia
Studying Pseudoachondroplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The University of Texas Health Science Center, Houston
- Principal Investigator
- Karen Posey, PhDUniversity of Texas
- Intervention
- resveratrol(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- University of Texas Health Science Center, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03866200 on ClinicalTrials.gov